000 | 01774 a2200481 4500 | ||
---|---|---|---|
005 | 20250516133050.0 | ||
264 | 0 | _c20130826 | |
008 | 201308s 0 0 eng d | ||
022 | _a1573-2568 | ||
024 | 7 |
_a10.1007/s10620-013-2558-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZucchetti, Andrés E | |
245 | 0 | 0 |
_aHormonal modulation of hepatic cAMP prevents estradiol 17β-D-glucuronide-induced cholestasis in perfused rat liver. _h[electronic resource] |
260 |
_bDigestive diseases and sciences _cJun 2013 |
||
300 |
_a1602-14 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 11 |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xmetabolism |
650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xtherapeutic use |
650 | 0 | 4 |
_aAlanine _xtherapeutic use |
650 | 0 | 4 |
_aAlbuterol _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aCholestasis _xetiology |
650 | 0 | 4 |
_aCyclic AMP _xagonists |
650 | 0 | 4 | _aEstradiol |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucagon _xtherapeutic use |
650 | 0 | 4 |
_aHormones _xtherapeutic use |
650 | 0 | 4 |
_aLiver _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_arab GTP-Binding Proteins _xmetabolism |
700 | 1 | _aBarosso, Ismael R | |
700 | 1 | _aBoaglio, Andrea C | |
700 | 1 | _aLuquita, Marcelo G | |
700 | 1 | _aRoma, Marcelo G | |
700 | 1 | _aCrocenzi, Fernando A | |
700 | 1 | _aSánchez Pozzi, Enrique J | |
773 | 0 |
_tDigestive diseases and sciences _gvol. 58 _gno. 6 _gp. 1602-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10620-013-2558-4 _zAvailable from publisher's website |
999 |
_c22467847 _d22467847 |